Dashboard
Manage Tickers

RZLT Rezolute, Inc.

Nasdaq rezolutebio.com


$ 9.57 $ 0.11 (1.16 %)    

Friday, 07-Nov-2025 11:52:41 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 600.86 $ -7.47 (-1.23 %)
DIA $ 466.17 $ -2.02 (-0.43 %)
SPY $ 663.11 $ -4.83 (-0.72 %)
TLT $ 89.79 $ 0.43 (0.48 %)
GLD $ 369.45 $ 1.52 (0.41 %)
$ 9.6
$ 9.45
$ 9.55 x 7
$ 9.57 x 10
$ 9.37 - $ 9.69
$ 2.22 - $ 10.04
1,515,831
na
890.18M
$ 35.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 09-17-2025 06-30-2025 10-K
3 05-13-2025 03-31-2025 10-Q
4 02-12-2025 12-31-2024 10-Q
5 11-07-2024 09-30-2024 10-Q
6 09-19-2024 06-30-2024 10-K
7 05-15-2024 03-31-2024 10-Q
8 02-13-2024 12-31-2023 10-Q
9 11-13-2023 09-30-2023 10-Q
10 09-14-2023 06-30-2023 10-K
11 05-11-2023 03-31-2023 10-Q
12 02-10-2023 12-31-2022 10-Q
13 11-09-2022 09-30-2022 10-Q
14 09-15-2022 06-30-2022 10-K
15 05-12-2022 03-31-2022 10-Q
16 02-09-2022 12-31-2021 10-Q
17 11-12-2021 09-30-2021 10-Q
18 09-15-2021 06-30-2021 10-K
19 05-17-2021 03-31-2021 10-Q
20 02-10-2021 12-31-2020 10-Q
21 11-12-2020 09-30-2020 10-Q
22 10-13-2020 06-30-2020 10-K
23 05-14-2020 03-31-2020 10-Q
24 02-12-2020 12-31-2019 10-Q
25 11-14-2019 09-30-2019 10-Q
26 09-10-2019 06-30-2019 10-K
27 05-10-2019 03-31-2019 10-Q
28 02-14-2019 12-31-2018 10-Q
29 12-14-2018 09-30-2018 10-Q
30 10-15-2018 06-30-2018 10-K
31 05-15-2018 03-31-2018 10-Q
32 02-14-2018 12-31-2017 10-Q
33 11-14-2017 09-30-2017 10-Q
34 09-22-2017 06-30-2017 10-K
35 05-15-2017 03-31-2017 10-Q
36 02-02-2017 12-31-2016 10-Q
37 11-14-2016 09-30-2016 10-Q
38 09-28-2016 06-30-2016 10-K
39 05-16-2016 03-31-2016 10-Q
40 02-16-2016 12-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rezolute-q1-eps-018-beats-026-estimate
Rezolute Q1 EPS $(0.18) Beats $(0.26) Esti...
11/06/2025 22:11:11

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.26) by 3...

citizens-maintains-market-outperform-on-rezolute-raises-price-target-to-17
Citizens Maintains Market Outperform on Re...
10/29/2025 16:02:10

Citizens analyst Jason N. Butler maintains Rezolute (NASDAQ:RZLT) with a Market Outperform and raises the price target from ...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/06/2025 17:35:26

guggenheim-reiterates-buy-on-rezolute-maintains-15-price-target
Guggenheim Reiterates Buy on Rezolute, Mai...
09/22/2025 12:47:01

Guggenheim analyst Debjit Chattopadhyay reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $15 price target.

maxim-group-maintains-buy-on-rezolute-raises-price-target-to-20
Maxim Group Maintains Buy on Rezolute, Rai...
09/19/2025 16:49:50

Maxim Group analyst Jason McCarthy maintains Rezolute (NASDAQ:RZLT) with a Buy and raises the price target from $15 to $20.

btig-reiterates-buy-on-rezolute-maintains-17-price-target
BTIG Reiterates Buy on Rezolute, Maintains...
09/18/2025 09:40:33

BTIG analyst Julian Harrison reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $17 price target.

rezolute-q4-eps-026-misses-022-estimate
Rezolute Q4 EPS $(0.26) Misses $(0.22) Est...
09/17/2025 20:08:35

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.22) by...

hc-wainwright--co-reiterates-buy-on-rezolute-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Rezo...
09/03/2025 11:12:30

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

rezolute-secures-fda-alignment-on-streamlined-phase-3-uplift-trial-of-ersodetug-for-tumor-hyperinsulinism-study-simplified-to-16-patient-open-label-design-supported-by-sunrize-confirmatory-data-expected-dec-2025
Rezolute Secures FDA Alignment On Streamli...
09/02/2025 10:17:33

Core News & Articles
10 Health Care Stocks Whale Activity In To...
08/13/2025 17:35:30

rezolute-files-prospectus-to-resale-of-13m-shares-of-common-stock-by-selling-stockholders
Rezolute Files Prospectus To Resale Of 1.3...
07/17/2025 21:32:51

-SEC Filing

rezolute-to-present-late-breaking-phase-3-data-on-rare-hypoglycemia-treatment-at-endo-2025
Rezolute to Present Late-Breaking Phase 3 ...
07/09/2025 11:34:02

Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treati...

rezolute-completes-enrollment-in-phase-3-sunrize-study-of-ersodetug-in-patients-with-congenital-hyperinsulinism
Rezolute Completes Enrollment In Phase 3 s...
05/28/2025 12:04:55

rezolute-q3-eps-027-misses-023-estimate
Rezolute Q3 EPS $(0.27) Misses $(0.23) Est...
05/13/2025 20:27:12

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.23) by...

rezolute-fda-grants-breakthrough-therapy-designation-to-investigational-therapy-ersodetug-for-treatment-of-hypoglycemia-caused-by-tumor-hi
Rezolute: FDA Grants Breakthrough Therapy ...
05/05/2025 12:01:41

Registrational study in patients with tumor hyperinsulinism (HI) expected to commence mid-yearDesignation underscores need for ...

hc-wainwright--co-reiterates-buy-on-rezolute-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Rezo...
04/28/2025 17:41:46

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

rezolute-thrilled-with-positive-review-of-genetic-disorder-trial-expects-topline-results-in-december
Rezolute 'Thrilled' With Positive Review O...
04/23/2025 19:50:43

Rezolute advances HI drug trial after DMC review and secures $90 million in funding through stock offering to support development.

rezolute-announces-pricing-of-offering-of-90m-at-335-per-share-of-common-stock-and-pre-funded-warrants
Rezolute Announces Pricing Of Offering Of ...
04/23/2025 12:14:17

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
04/23/2025 12:06:43

rezolute-announces-the-data-monitoring-committees-recommendation-to-continue-phase-3-sunrize-study-as-planned-in-patients-with-congenital-hi-without-an-increase-in-the-study-sample-size
Rezolute Announces The Data Monitoring Com...
04/23/2025 12:03:15

Independent Data Monitoring Committee (the "DMC") recommends continuation of sunRIZE trial as planned with no need to i...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION